Mandate

Vinge has advised Gränges in merger control matters in connection with the acquisition of Impexmetal (Aluminium Konin)

December 08, 2020 EU, Competition and Regulatory

Vinge has advised Gränges AB (publ) in merger control matters in connection with the acquisition of Impexmetal (Aluminium Konin).

The concentration was notified to, inter alia, the European Commission. After a thorough pre-nonfiction phase and formal review, which included several market contacts, the concentration, which results in a combination of the parties’ production of flat rolled aluminium products in the EU, was unconditionally approved by the European Commission after a phase 1 review on the 23 September 2020.

The decision is available at:  https://ec.europa.eu/competition/mergers/cases1/202050/m9560_488_3.pdf

Vinge’s team consisted mainly of Pär Remnelid, Johan Wahlbom and Julia Söderdahl.

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025